Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation
Phase of Trial: Phase I
Latest Information Update: 11 May 2017
At a glance
- Drugs Plerixafor (Primary) ; Antineoplastics
- Indications Chronic lymphocytic leukaemia; Lymphoma; Multiple myeloma
- Focus Adverse reactions
- 02 Dec 2015 Planned End Date changed from 1 May 2016 to 1 Sep 2017 as reported by ClinicalTrials.gov.
- 02 Dec 2015 Planned primary completion date changed to 1 Mar 2017 as reported by ClinicalTrials.gov.
- 10 Jul 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.